Pravitt Gourh, M.D.
Assistant Clinical Investigator
Scleroderma Genomics and Health Disparities Unit
Dr. Gourh's lab is using genomic technologies to understand autoimmune, fibrotic, and health disparity conditions. Dr. Gourh's lab has taken a comprehensive approach towards identifying both common and rare variants associated with disease susceptibility.
To identify common variants, Dr. Gourh's lab utilizes SNP microarray genotyping and imputation for fine-mapping, followed by a genome-wide association study (GWAS) to identify disease-associated genetic variants. To identify rare variants, Dr. Gourh's lab utilizes high-throughput DNA sequencing platforms for whole genome or whole exome sequencing followed by variant annotation and scoring to prioritize causal variants. Dr. Gourh's lab also uses gene mapping tools to identify genetic loci associated with traits in recently admixed populations (admixture mapping).
Another goal of Dr. Gourh's lab is to understand transcriptional regulation of these disease-associated genes using cutting-edge technologies, including RNA-seq, eQTL, Hi-C, ATAC-seq, ChIP-seq, CUT&RUN, CRISPR-Cas9 genetic screens, and bioinformatics.
Dr. Gourh has been involved in the establishment of the Genome Research in African American Scleroderma Patients (GRASP) consortium. It is comprised of 25 centers across the United States. Dr. Gourh's lab's goal is to enroll scleroderma patients, and perform genomic mapping to identify SSc-specific risk variants, contributing to disease risk and severity.
Antibodies directed towards self-antigens are a hallmark of autoimmune diseases. Dr. Gourh's lab is interested in understanding the timing and development of autoantibodies in the pre-clinical phase of autoimmune diseases. Human leukocyte antigen (HLA) genes have the strongest influence on autoimmune disease susceptibility and these HLA alleles encode variations in the antigen-binding grooves of the HLA molecules that determine their binding affinity for specific antigens presented to T cells. T cells recognize these peptide-HLA complexes by the T cell receptor (TCR), located on the surface of T cells. We are using next generation sequencing technologies to analyze the extreme diversity of the TCR repertoire. Elucidating the role of the HLA molecules in antigen recognition, peptide presentation and autoimmunity induction is an important area of focus. Dr. Gourh's lab is also exploring the link between HLA alleles, autoantibodies, and environmental triggers in the pathogenesis of autoimmune diseases.
Pravitt Gourh, M.D. is a board-certified rheumatologist with a long-standing interest in scleroderma and autoimmunity. He currently directs a translational research program focused on understanding the genetics of pediatric and adult scleroderma, biomarker discovery, and disease classification.
Dr. Gourh received his medical degree in India, after which he conducted postdoctoral research in genetics at the McGovern Medical School, part of the University of Texas Health Science Center at Houston. He then joined the faculty and went on to become Assistant Professor of Medicine. Dr. Gourh completed his medical training at Houston, followed by an adult rheumatology fellowship at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). He became a Henry Metzger Scholar in Translational Medicine at the NIAMS and began studying the genetics of African American scleroderma patients. Dr. Gourh was appointed as an Assistant Clinical Investigator in 2019 and is also an attending physician on the NIH Rheumatology Consultation Service.
- Gourh P, Safran SA, Alexander T, Boyden SE, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA Jr, Ramos PS, Silver RM, Steen VD, Varga J, Hsu V, Saketkoo LA, Schiopu E, Khanna D, Gordon JK, Kron B, Criswell LA, Gladue H, Derk CT, Bernstein EJ, Bridges SL Jr, Shanmugam VK, Kolstad KD, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Steinbach PJ, Chandrasekharappa SC, Mullikin JC, Adeyemo A, Rotimi C, Wigley FM, Kastner DL, Boin F, Remmers EF. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A. 2020;117(1):552-562.
- Gourh P, Remmers EF, Boyden SE, Alexander T, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA Jr, Steen VD, Ramos PS, Silver RM, Korman B, Varga J, Schiopu E, Khanna D, Hsu V, Gordon JK, Saketkoo LA, Gladue H, Kron B, Criswell LA, Derk CT, Bridges SL Jr, Shanmugam VK, Kolstad KD, Chung L, Jan R, Bernstein EJ, Goldberg A, Trojanowski M, Kafaja S, Maksimowicz-McKinnon KM, Mullikin JC, Adeyemo A, Rotimi C, Boin F, Kastner DL, Wigley FM. Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. Arthritis Rheumatol. 2018;70(10):1654-1660.
- Morgan ND, Shah AA, Mayes MD, Domsic RT, Medsger TA Jr, Steen VD, Varga J, Carns M, Ramos PS, Silver RM, Schiopu E, Khanna D, Hsu V, Gordon JK, Gladue H, Saketkoo LA, Criswell LA, Derk CT, Trojanowski MA, Shanmugam VK, Chung L, Valenzuela A, Jan R, Goldberg A, Remmers EF, Kastner DL, Wigley FM, Gourh P, Boin F. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. Medicine (Baltimore). 2017;96(51):e8980.
- Fike A, Hartman J, Redmond C, Williams SG, Ruiz-Perdomo Y, Chu J, Hasni S, Ward MM, Katz JD, Gourh P. Risk factors for COVID-19 and rheumatic disease flare in a US cohort of Latino patients. Arthritis Rheumatol. 2021.
- Subedi A, Williams SG, Yao L, Maharjan S, Strauss J, Sharon E, Thomas A, Apolo AB, Gourh P, Hasni SA, Gulley JL, Kaplan MJ, Katz JD, Gupta S. Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis. JAMA Netw Open. 2020;3(2):e200032.
Related Scientific Focus Areas
Genetics and Genomics
View additional Principal Investigators in Genetics and Genomics
View additional Principal Investigators in Health Disparities
View additional Principal Investigators in Computational Biology
This page was last updated on Tuesday, August 9, 2022